Expectant parents are bombarded with costly propositions. Diverting attention to all the "what ifs" can be distracting, as compared to "what actually is." Storing their infant's cord blood can be preoccupying. But is it worth it?
Twelve patients who tried stem cell injections were hospitalized with infections, according to a published report, one that should cause patients concern. More important is that they should investigate stem cell treatments, for conditions such as cartilage injuries to their joints, before committing to one of these procedures.
The FDA's current regulatory framework is out of whack -- and it comes at the expense of patient safety. The Wild West of "stem cell" clinics continues. This time, patients are hospitalized with blood infections to spinal abscesses.
When it comes to medical fundraising on social media, you may be gambling with the highest of stakes.
Does Geisinger Health System's latest pitch, to offer DNA sequencing as part of routine testing at the primary care visit, promise more than it can deliver?
Newly released guidelines from the U.S. Food and Drug Administration (FDA) suggest illegitimate, unproven stem cell uses might become a thing of the past.
An international team of medical experts recently published a global call to action in an effort to curb the unethical, unsubstantiated use of stem-cell based therapies driving medical tourism. When greed trumps science, we all lose.
We all understand the impact of a gaping wound, or the wasted appearance of a body overrun by cancer. But often there are more silent and invisible conditions that not only invoke a physical furor, but emotional and psychological pain as well. Type 1 Diabetes is such a malady. Thankfully, major advances are ongoing.
Researchers at the University of Michigan have developed a drug which blocks messages that direct stem cells to differentiate, forcing them to reverse course to a more embryonic state.
The urine of premature infants is chock full of progenitor cells, which could have major clinical significance in restoring function to damaged kidneys.
Type 1 diabetes occurs when the body fails to produce insulin. But Belgian researchers have come up with a potential solution: reprogramming pancreatic cells to produce insulin and respond to glucose. They announced this week that it's working well in models, with study in humans to hopefully take place.
For the first time, researchers created what they call Alzheimer s in a Dish human brain cells that develop defining Alzheimer s structures in a petri dish. This incredible achievement could redefine how Alzheimer s and potential treatment drugs are studied. Until now, researchers were only able to use mice that developed an imperfect form of the disease.